Market Place
Sourcing Support
All News #Library
Biotech
Allarity Therapeutics Reports 2025 Results and Corporate Progress
31 Mar 2026 //
GLOBENEWSWIRE
Allarity Therapeutics Secures $20M for Stenoparib`s FDA Approval
06 Mar 2026 //
GLOBENEWSWIRE
Allarity Therapeutics Opens Phase 2 Trial With US Veterans
03 Feb 2026 //
GLOBENEWSWIRE
Allarity Therapeutics Unveils Q3 Financials & Business Update
14 Nov 2025 //
GLOBENEWSWIRE
Allarity CEO to Present at Biomarkers & Precision Medicine 2025
17 Sep 2025 //
GLOBENEWSWIRE
Allarity Gets FDA Fast Track for Stenoparib in Ovarian Cancer
26 Aug 2025 //
GLOBENEWSWIRE
Allarity`s Ph2 Stenoparib Lung Cancer Trial Fully Funded By VA
06 Mar 2025 //
GLOBENEWSWIRE
Allarity Therapeutics to Present at Biomarkers 2024
28 Feb 2024 //
GLOBENEWSWIRE
Allarity Therapeutics to Present at Biomarkers Europe 2023
02 Oct 2023 //
GLOBENEWSWIRE
Allarity Therapeutics Appoints Three Accomplished Biotechnology Executives
24 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.